Ben Leder
Physician · Massachusetts General Hospital
Credentials: · · ·
History
- 1998–2000
- 1995–1998
Internal Medicine
- 1994–1995
- 1990–1994
Research
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
New England Journal of Medicine · 2009 · 798 citations
Gonadal steroids and body composition, strength, and sexual function in men
New England Journal of Medicine · 2013 · Last of 11 authors · 551 citations
The Lancet · 2015 · First of 7 authors · Corresponding · 447 citations
- JT
25 papers · 6 as a fellow
- JF
19 papers
- RN
11 papers
- SR
11 papers
- AU
8 papers · 2 as a fellow
8 papers
- MB
7 papers
- WF
7 papers
Grants
- 2024–2027
Combined Anabolic Therapy in Postmenopausal Osteoporosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $587.8K · Massachusetts General Hospital
- 2021–2025
Limited-Duration Anabolic Therapy in Postmenopausal Osteoporosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $654.8K · Massachusetts General Hospital
- 2019–2024
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $2.2M · Massachusetts General Hospital
- 2018–2021
Combination Osteoporosis Therapy and Fracture Reduction
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R34
Contact PI · $452.8K · Massachusetts General Hospital
Clinical trials
- 2025–2028
Principal investigator · Recruiting · Phase 4
Massachusetts General Hospital
- 2023–2028
Mechanisms of Anabolic Osteoporosis Therapy
Principal investigator · Recruiting
Massachusetts General Hospital
- 2022–2027
Anabolic Therapy in Postmenopausal Osteoporosis
Principal investigator · Active not recruiting · Phase 4
Massachusetts General Hospital
- 2019–2022
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
Principal investigator · Completed · Phase 4
Massachusetts General Hospital